Prestige Consumer Healthcare Inc.
PBHNYSE
$49.92
↓ -1.3%Jul 17 close · end-of-day
Price
1Y↓ -33.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$2.4B
Enterprise Value
$3.4B
P/E
12.8
P/S
2.2
P/B
1.3
EV/EBITDA
9.9
PEG
—
FCF Yield
10.1%
Dividend Yield
—
Revenue (TTM)
$1.1B
Net Income (TTM)
$190.3M
Free Cash Flow (TTM)
$246.4M
Gross Margin
54.7%
Operating Margin
28.4%
Net Margin
17.5%
ROE
10.1%
ROIC
8.7%
Debt / Equity
0.5
Net Cash
-$930.1M
Return 1Y
-33.6%
Company profile
Prestige Consumer Healthcare Inc. develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies.
- CEO
- Ronald M. Lombardi
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 540
- Headquarters
- New York
- Website
- prestigebrands.com
Management & directors
- Zerillo JeffreySenior VP Operations
- Lombardi Ronald M.Chief Executive Officer
- Mekhail AdelEVP, Marketing & Sales
- Sacco ChristineCFO & COO
- P'Pool WilliamSee Remarks
- Rosado Jose LuisSee Remarks
Roles derived from SEC Form 4 filings.
Earnings
PBH Q4 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$281.6M↓ -5.0%
Diluted EPS$1.13↑ +13.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | $943.4M | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| Gross profit | $547.5M | $620.6M | $625.3M | $624.4M | $634.5M | $595.6M |
| Operating income | $297.4M | $329.9M | -$22.4M | $342.4M | $336.8M | $309.4M |
| Net income | $164.7M | $205.4M | -$82.3M | $209.3M | $214.6M | $190.3M |
| Diluted EPS | $3.25 | $4.04 | -$1.65 | $4.17 | $4.29 | $3.91 |
| Operating cash flow | $235.6M | $259.9M | $229.7M | $248.9M | $251.5M | $257.6M |
| Free cash flow | $213.4M | $250.3M | $221.9M | $239.4M | $243.3M | $246.4M |
| Gross margin | 58.0% | 57.1% | 55.4% | 55.5% | 55.8% | 54.7% |
| Operating margin | 31.5% | 30.4% | -2.0% | 30.4% | 29.6% | 28.4% |
| Net margin | 17.5% | 18.9% | -7.3% | 18.6% | 18.9% | 17.5% |
| Line item | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $267.1M | $283.8M | $290.3M | $296.5M | $249.5M | $274.1M | $283.4M | $281.6M |
| Gross profit | $146.0M | $157.4M | $161.0M | $170.0M | $140.3M | $151.6M | $157.4M | $146.3M |
| Operating income | $72.0M | $84.3M | $92.0M | $88.4M | $71.8M | $79.7M | $82.5M | $75.5M |
| Net income | $49.1M | $54.4M | $61.0M | $50.1M | $47.5M | $42.2M | $46.7M | $53.9M |
| Diluted EPS | $0.98 | $1.09 | $1.22 | $1.00 | $0.95 | $0.86 | $0.97 | $1.13 |
| Operating cash flow | $54.8M | $69.8M | $65.1M | $61.8M | $79.0M | $57.5M | $78.3M | $42.8M |
| Free cash flow | $53.6M | $67.8M | $63.5M | $58.4M | $78.2M | $55.4M | $75.3M | $37.6M |
| Gross margin | 54.7% | 55.5% | 55.5% | 57.3% | 56.2% | 55.3% | 55.5% | 51.9% |
| Operating margin | 27.0% | 29.7% | 31.7% | 29.8% | 28.8% | 29.1% | 29.1% | 26.8% |
| Net margin | 18.4% | 19.2% | 21.0% | 16.9% | 19.0% | 15.4% | 16.5% | 19.1% |
Company news
Jul 6, 2026
- 14d agoIs the Options Market Predicting a Spike in Prestige Consumer Healthcare Stock?finance.yahoo.com
- 14d agoPrestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Datefinance.yahoo.com
Jun 30, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-11 | Zerillo Jeffrey· Senior VP Operations | Sale | 351 | $52.28 | $18,350.28 | filing |
| 2026-05-07 | Lombardi Ronald M.· Chief Executive Officer | Tax withholding | 2,543 | $54.59 | $138,822.37 | filing |
| 2026-05-07 | Sacco Christine· CFO & COO | Tax withholding | 991 | $54.59 | $54,098.69 | filing |
| 2026-05-07 | Mekhail Adel· EVP, Marketing & Sales | Tax withholding | 487 | $54.59 | $26,585.33 | filing |
| 2026-05-07 | Zerillo Jeffrey· Senior VP Operations | Tax withholding | 351 | $54.59 | $19,161.09 | filing |
| 2026-05-07 | Zerillo Jeffrey· Senior VP Operations | Sale | 305 | $54.36 | $16,579.80 | filing |
| 2026-05-05 | Lombardi Ronald M.· Chief Executive Officer | Tax withholding | 2,197 | $55.75 | $122,482.75 | filing |
| 2026-05-05 | Sacco Christine· CFO & COO | Tax withholding | 1,267 | $55.75 | $70,635.25 | filing |
| 2026-05-05 | Zerillo Jeffrey· Senior VP Operations | Sale | 1,207 | $54.99 | $66,372.93 | filing |
| 2026-05-05 | Zerillo Jeffrey· Senior VP Operations | Sale | 346 | $55.32 | $19,140.72 | filing |
| 2026-05-05 | Zerillo Jeffrey· Senior VP Operations | Tax withholding | 307 | $55.75 | $17,115.25 | filing |
| 2026-05-04 | Lombardi Ronald M.· Chief Executive Officer | Tax withholding | 16,789 | $55.31 | $928,599.59 | filing |
| 2026-05-04 | Sacco Christine· CFO & COO | Tax withholding | 3,434 | $55.31 | $189,934.54 | filing |
| 2026-05-04 | P'Pool William· See Remarks | Tax withholding | 1,888 | $55.31 | $104,425.28 | filing |
| 2026-05-04 | Mekhail Adel· EVP, Marketing & Sales | Tax withholding | 1,695 | $55.31 | $93,750.45 | filing |
| 2026-05-04 | Zerillo Jeffrey· Senior VP Operations | Tax withholding | 1,243 | $55.31 | $68,750.33 | filing |
| 2026-05-04 | Lombardi Ronald M.· Chief Executive Officer | Award | 19,662 | $0.00 | $0.00 | filing |
| 2026-05-04 | Sacco Christine· CFO & COO | Award | 7,008 | $0.00 | $0.00 | filing |
| 2026-05-04 | Sacco Christine· CFO & COO | Award | 11,976 | $0.00 | $0.00 | filing |
| 2026-05-04 | P'Pool William· See Remarks | Award | 3,675 | $0.00 | $0.00 | filing |
| 2026-05-04 | P'Pool William· See Remarks | Award | 4,187 | $0.00 | $0.00 | filing |
| 2026-05-04 | Zerillo Jeffrey· Senior VP Operations | Award | 2,450 | $0.00 | $0.00 | filing |
| 2026-05-04 | Zerillo Jeffrey· Senior VP Operations | Award | 2,857 | $0.00 | $0.00 | filing |
| 2026-05-04 | Mekhail Adel· EVP, Marketing & Sales | Award | 3,505 | $0.00 | $0.00 | filing |
| 2026-05-04 | Mekhail Adel· EVP, Marketing & Sales | Award | 4,014 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.